Harvard Medical School, Dana-Farber Cancer Institute
44 Binney Street
Boston, Massachusetts 02115
Email Address: firstname.lastname@example.org
Dr. Arthur T. Skarin is Associate Professor of Medicine at Harvard Medical School. His research interest is the Development of New Therapeutic Programs in Thoracic Cancers. Dr. Skarin’s research focuses on diagnosis, staging, and management of benign and malignant tumors of the thorax. He is involved with lung cancer screening and prevention studies, and lung cancer management involving treatment modalities including thoracic surgery, radiation therapy, traditional chemotherapy, and multimodality management. He is also involved with developing innovative treatments including novel chemotherapeutic agents, antiangiogenic agents, antisense oligonucleotide protocols, and tumor vaccines.
According to the Dana-Farber Cancer Institute website, “Research protocols under development include Dana-Farber Cancer Institute studies and those under evaluation by the Cancer and Leukemia Group B, which include phase I new drug protocols (escalation of doses to determine safe treatment levels), phase II studies (to determine effectiveness and efficacy), and phase III protocols (to compare the value of a new regimen or drug with that of standard treatment).”
Dr. Skarin attended the State University of New York at Buffalo where he received his Medical Degree (M.D.) in 1961. He completed his postgraduate training in Internal Medicine at the Millard Fillmore Teaching Hospital in Buffalo, New York. Dr. Skarin completed his Fellowship in Hematology and Oncology at Boston City Hospital in Boston, Massachusetts and he joined the staff at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in 1970. He served as Clinical Director of the Hematology Laboratory from 1970-1998 and Medical Director from 1975 until recently, in 2006.
Dr. Skarin was a Fellow, American College of Chest Physicians, in 1986, and he received the Teacher of the Year, Fellows Award presented by the Dana-Farber Cancer Institute in 1996. He also has more than a dozen books to his credit including:
Breast Cancer: Dana-Farber Cancer Institute Handbook – Dana-Farber Cancer Institute Handbooks; Colorectal Cancer: Dana-Farber Cancer Institute Handbook – Dana-Farber Cancer Institute Handbooks; Lung Cancer: Dana-Farber Cancer Institute Handbook -Dana-Farber Cancer Institute Handbooks; Prostate Cancer: Dana-Farber Cancer Institute Handbook – Dana-Farber Cancer Institute Handbooks; Atlas of Diagnostic Oncology; Slide Atlas of Diagnostic Oncology Hybrid Single User; Slide Atlas of Lung Cancer and Tumours of the Heart and Mediastinum -Slide Atlas of Diagnostic Oncology; Slide Atlas of Cancer of the Gastrointestinal Tract-Slide Atlas of Diagnostic Oncology; Non-Hodgkins lymphoma management progress and prospects; Slide Atlas of Diagnostic Oncology, and Slide Atlas of Acute and Chronic Leukemias – Slide Atlas of Diagnostic Oncolology.